Non-Invasive Facial Lifting Procedure Emface Surpasses 1 Million Treatments
New submental and under-eye applicators expand its non-invasive facial rejuvenation capabilities.
New submental and under-eye applicators expand its non-invasive facial rejuvenation capabilities.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.